Cerecyte Microcoils Featured in Key Presentations at the World Federation of Interventional Neuroradiology.

Publication: Business Wire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2005 Business Wire

SUNNYVALE, Calif. -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced that its Cerecyte(R) microcoils appear to improve intracranial aneurysm occlusion rates compared with bare platinum microcoils, according to two studies presented at the 8th Congress of the World Federation of Interventional and Therapeutic Neuroradiology held October 19-23 in Venice, Italy. Micrus Endovascular's Cerecyte microcoils incorporate a bioactive filament with the Company's proprietary, three-dimensional microcoils that easily deploy within a cerebral aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes.

In the first study presented by Dr. Martin Bendszus of the University of Wurzburg, Germany, 18 of 26 patients treated for cerebral aneurysms with Cerecyte coils obtained complete aneurysm...

Read the full article for free courtesy of your local library.